A Prospective, Real-World, Multinational Study of Naloxegol for Patients with Cancer Pain Diagnosed with Opioid-Induced Constipation—The NACASY Study
The Naloxegol Cancer Study (NACASY) was a multinational European study aimed to evaluate the 4-week safety and efficacy of naloxegol in a real-world setting in patients with cancer pain diagnosed with opioid-induced constipation. The primary safety endpoint was the incidence of adverse events leadin...
Main Authors: | Andrew Davies, Saverio Cinieri, Denis Dupoiron, Sofia España Fernandez, Johan Leclerc, Vincenzo Montesarchio, Kyriaki Mystakidou, Judith Serna, Jan Tack, on behalf of the NACASY Study Group |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/5/1128 |
Similar Items
-
Efficacy and Safety of Naloxegol in Patients with Chronic Non-Cancer Pain Who Experience Opioid-Induced Constipation: A Pooled Analysis of Two Global, Randomized Controlled Studies
by: Chey WD, et al.
Published: (2023-08-01) -
Can Naloxegol Therapy Improve Quality of Life in Patients with Advanced Cancer?
by: Rita Ostan, et al.
Published: (2021-11-01) -
Naloxegol in opioid-induced constipation: a new paradigm in the treatment of a common problem
by: Yoon SC, et al.
Published: (2017-07-01) -
A Nationwide Hospital Claims Database Analysis of Real-World Patterns of Laxative Use for Opioid-Induced Constipation in Japanese Patients with Cancer
by: Takahiro Higashibata, et al.
Published: (2023-05-01) -
Naloxegol and Postoperative Urinary Retention: A Randomized Trial
by: Alparslan Turan, et al.
Published: (2022-01-01)